BRPI0807477A2 - Uso de um polipeptídeo isolado, polipeptídeo isolado, composição farmacêutica, e, métdo de tratamento de um mamífero - Google Patents

Uso de um polipeptídeo isolado, polipeptídeo isolado, composição farmacêutica, e, métdo de tratamento de um mamífero

Info

Publication number
BRPI0807477A2
BRPI0807477A2 BRPI0807477-1A2A BRPI0807477A BRPI0807477A2 BR PI0807477 A2 BRPI0807477 A2 BR PI0807477A2 BR PI0807477 A BRPI0807477 A BR PI0807477A BR PI0807477 A2 BRPI0807477 A2 BR PI0807477A2
Authority
BR
Brazil
Prior art keywords
isolated polypeptide
mammal
treating
pharmaceutical composition
polypeptide
Prior art date
Application number
BRPI0807477-1A2A
Other languages
English (en)
Inventor
Goeran Andersson
Vanessa Van Harmelen
Pernilla Lang
Peter Arner
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Publication of BRPI0807477A2 publication Critical patent/BRPI0807477A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03002—Acid phosphatase (3.1.3.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0807477-1A2A 2007-02-14 2008-02-13 Uso de um polipeptídeo isolado, polipeptídeo isolado, composição farmacêutica, e, métdo de tratamento de um mamífero BRPI0807477A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88982007P 2007-02-14 2007-02-14
SE0700363 2007-02-14
PCT/SE2008/050172 WO2008100220A1 (en) 2007-02-14 2008-02-13 Compositions for increasing body weight, use and methods

Publications (1)

Publication Number Publication Date
BRPI0807477A2 true BRPI0807477A2 (pt) 2014-05-13

Family

ID=39512792

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807477-1A2A BRPI0807477A2 (pt) 2007-02-14 2008-02-13 Uso de um polipeptídeo isolado, polipeptídeo isolado, composição farmacêutica, e, métdo de tratamento de um mamífero

Country Status (6)

Country Link
US (1) US20100120682A1 (pt)
EP (1) EP2121003A1 (pt)
AU (1) AU2008216906A1 (pt)
BR (1) BRPI0807477A2 (pt)
CA (1) CA2677452A1 (pt)
WO (1) WO2008100220A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2667007C2 (ru) * 2016-11-01 2018-09-13 Олег Ильич Эпштейн Ветеринарная композиция для повышения эффективности иммунизации и профилактики и/или лечения инфекционных заболеваний у млекопитающих и птиц и способ повышения эффективности иммунизации и профилактики и/или лечения инфекционных заболеваний у млекопитающих и птиц

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ206097A3 (cs) * 1995-10-30 1999-02-17 Smithkline Beecham Corporation Způsob inhibice kathepsinu K
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US20020041863A1 (en) * 1997-03-14 2002-04-11 Masamichi Kojiro Preventive and/or therapeutic agent for cachexia
EP0984795B1 (en) * 1997-04-22 2003-09-24 Washington Research Foundation Bone grafts and prostheses coated with tartrate-resistant acid phosphatase
WO2002040684A2 (en) * 2000-11-14 2002-05-23 Bayer Aktiengesellschaft Polynucleotide and polypeptide sequences of human purple acid phosphate
WO2002055710A2 (en) * 2001-01-11 2002-07-18 Bayer Ag Regulation of human purple acid phosphatase
US6760182B2 (en) * 2001-02-19 2004-07-06 Seagate Technology Llc Temperature compensated fly height control
DE60229114D1 (en) * 2001-03-02 2008-11-13 Axys Pharm Inc Cathepsincystein-proteasehemmer
TWI325317B (en) * 2001-09-05 2010-06-01 Eisai R&D Man Co Ltd Appetite-stimulating agents and remedies for anorexia
WO2003024408A2 (en) * 2001-09-20 2003-03-27 University Of Rochester Compositions and methods involved in bone growth
EP1407779A1 (en) * 2002-10-10 2004-04-14 Gastrotech A/S Use of ghrelin for treating low body weight and body fat in gastrectomized individuals
US8012950B2 (en) * 2003-08-29 2011-09-06 Wisconsin Alumni Research Foundation Method to diagnose and treat degenerative joint disease

Also Published As

Publication number Publication date
AU2008216906A1 (en) 2008-08-21
CA2677452A1 (en) 2008-08-21
US20100120682A1 (en) 2010-05-13
WO2008100220A1 (en) 2008-08-21
EP2121003A1 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI1005322A2 (pt) anticorpo, composição farmacêutica e uso de pelo menos um anticorpo
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0915137A2 (pt) uso de pelo menos um composto, peptídeo, e, formulação farmacêutica
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BRPI0924177A2 (pt) Polipeptídeos, seu método de preparação, sua composição, sequência de nucleotídeo e uso
BRPI0918502A2 (pt) aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BRPI0915136A2 (pt) uso de pelo menos um composto, peptídeo, e, formulação farmacêutica
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
BR112012003842A2 (pt) composição farmacêutica, método de formulação e uso da mesma
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0714793A2 (pt) Análogos de niacina não enrubecedores e método de uso dos mesmos.
BRPI0921717A2 (pt) composto, sequência de peptídeo isolada, composição farmacêutica, uso de um composto, anticorpo, e, método de tratamento
BRPI0913188A2 (pt) moduladores de receptores 5-ht3, métodos de fabricação, e uso dos mesmos
BRPI0812942A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0716698A2 (pt) Composto, composição farmacêutica e uso de um composto

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A E 6A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.